GoodRx Holdings, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from GoodRx Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Debt due within a year is covered 33.6 times by its yearly operating cash. Higher than 93% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 2 of the last 3 years; profit grew in 3 of 3. Steadier than 85% of Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 23% of its market value (net debt). Lower than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
2.4×Over the last 3 years its own operating cash covered its investment spending (capex) 2.4 times.
Higher than 77% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 3/3Sales grew in 2 of the last 3 years; profit grew in 3 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by +4% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
+4% / -12%In 3 years sales changed by +4% while total assets changed by -12%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
33.6×Debt due within a year is covered 33.6 times by its yearly operating cash.
Higher than 93% of Healthcare companies in United States.
Cash Cushion Ratio
−23%Debt, after subtracting cash, equals 23% of its market value (net debt).
Lower than 85% of Healthcare companies in United States.
Tangible Assets Ratio
55%Of every $100 the company owns, $55 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 74% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 75% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
GoodRx Holdings, Inc. owes $0.72 for every $1 it owns. Net profit rose 86% in the year to Dec 2025.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
72.4Investors pay $72.4 for every $1 of GoodRx Holdings, Inc.'s yearly profit, higher than 85% of Healthcare companies in United States.
P/B ratio
1.91The share price is 1.91 times GoodRx Holdings, Inc.'s book value per share, lower than 61% of Healthcare companies in United States.
Market cap
$1.2 BThe total market value of all of GoodRx Holdings, Inc.'s shares at today's price (share price × number of shares), larger than 67% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$648 MWhat GoodRx Holdings, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.90Net worth divided by the number of shares. The share price of $3.62 is 1.9 times this, which is the P/B above.
Return on equity (ROE)
2.5%GoodRx Holdings, Inc. earned 2.5% on its shareholders' money over the last year, higher than 78% of Healthcare companies in United States.
Owes vs Owns
0.72×GoodRx Holdings, Inc. owes $0.72 for every $1 it owns (moderate), higher than 73% of Healthcare companies in United States.
Dividend yield
NoneGoodRx Holdings, Inc. does not currently pay a dividend.
Revenue growth
+1%Revenue rose 1% in the year to Dec 2025, and grew 1% a year on average over 3 years.
Profit growth
+86%Net profit rose 86% in the year to Dec 2025.
Profit margin
3.8%GoodRx Holdings, Inc. keeps $4 of every $100 of revenue as net profit.
Cash quality
5.5×Cash from GoodRx Holdings, Inc.'s business was 5.5× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
2.1×GoodRx Holdings, Inc.'s operating profit covered its interest costs 2.1 times in the year to Dec 2025.
Cash vs debt
Net debtGoodRx Holdings, Inc. had $281 M more debt than cash (net debt) at Dec 2025.
Questions
What is GoodRx Holdings, Inc.'s P/E ratio?
Investors pay $72.4 for every $1 of GoodRx Holdings, Inc.'s yearly profit, higher than 85% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For GoodRx Holdings, Inc.: $1.2 B ÷ $648 M (30 Jun 2026) = 1.9.
What is GoodRx Holdings, Inc.'s return on equity?
GoodRx Holdings, Inc. earned 2.5% on its shareholders' money over the last year, higher than 78% of Healthcare companies in United States.
How much does GoodRx Holdings, Inc. owe compared with what it owns?
GoodRx Holdings, Inc. owes $0.72 for every $1 it owns (moderate), higher than 73% of Healthcare companies in United States.
Does GoodRx Holdings, Inc. pay a dividend?
No. GoodRx Holdings, Inc. does not currently pay a dividend.
Is GoodRx Holdings, Inc.'s revenue growing?
Revenue rose 1% in the year to Dec 2025, and grew 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.